Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00012935 · ClinicalTrials.gov registry record · NA
Treatment Decision Intervention for Veterans With Prostate Cancer
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT00012935: Completed NA study, sponsored by US Department of Veterans Affairs.
NCT00012935 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00012935, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
Newly diagnosed localized prostate cancer patients face difficult decisions about treatment and management; including radiation therapy, radical prostatectomy, brachytherapy, and observation. Previous studies have cited patient preference and physician recommendation for treatment as major roles in treatment decisions.
Interventions
- BEHAVIORAL Help with decision making on prostate cancer treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Est. Completion | 2001-12 |
| Phase | NA |
What the finished NCT00012935 record still lists
NCT00012935 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which Help with decision making on prostate cancer treatment is the first listed.
NCT00012935 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00012935 about?
NCT00012935 is a clinical study titled "Treatment Decision Intervention for Veterans With Prostate Cancer". Newly diagnosed localized prostate cancer patients face difficult decisions about treatment and management; including radiation therapy, radical prostatectomy, brachytherapy, and observation. Previous studies have cited patient preference and physician recommendation for treatment as major roles in ...
What is the current status of trial NCT00012935?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. Estimated completion is 2001-12.
What interventions are being tested in trial NCT00012935?
The interventions under investigation include: Help with decision making on prostate cancer treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT00012935?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00012935's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning